Skip to main content
PLOS One logoLink to PLOS One
. 2024 May 7;19(5):e0302167. doi: 10.1371/journal.pone.0302167

Prevalence of undiagnosed diabetes mellitus and associated factors among adult residents of Mizan Aman town, Southwest Ethiopia: Community-based cross-sectional study

Tsegaye Atrese 1, Lata Fekadu 2, Guta Kune 2,*, Abel Shita 1, Kifle Woldemikael 2
Editor: Mohammed Hasen Badeso3
PMCID: PMC11075875  PMID: 38713690

Abstract

Background

Diabetes mellitus continues to be a significant global public health concern, and it is currently a public health issue in developing nations. In Ethiopia, about three fourth of adult population with diabetes are unaware of their diabetic condition. However, there is a limited research on this specific topic particularly in the study area.

Objective

To assess prevalence of undiagnosed diabetes mellitus and its associated factor among adult residents of Mizan Aman town, south West Ethiopia.

Methods and material

A community-based cross-sectional study was conducted from May 23 to July 7, 2022, on 627 adult residents of Mizan Aman town. A multi stage sampling technique was used to obtain 646 study units. Interviewer-administered structured questionnaires were employed to gather socio-demographic and behavioral data. Anthropometric measurements were obtained and blood samples were taken from each participants. The fasting blood glucose level was measured after an 8-hour gap following a meal, using a digital glucometer to analyze a blood sample. Data were cleaned and entered into Epi-data v 3.1 and exported to SPSS v. 26 for analysis. Bi-variable analysis was done to select candidate variables and multivariable logistic regression model was fitted to identify independent predictors of undiagnosed diabetes mellitus. Adjusted odds ratio (AOR) with 95% CI was computed and variables with p-value < 0.05 were declared to be predictors of undiagnosed diabetes mellitus.

Results

The study revealed that, the overall magnitude of undiagnosed diabetes mellitus was 8.13% (95% CI: 6.1, 10.6). Predictors of undiagnosed diabetes mellitus were; physical activity level less than 600 Metabolic equivalent/min per week (AOR = 3.39, 95%CI 1.08 to 10.66), family history of diabetes mellitus (AOR = 2.87, 95% CI 1.41, 5.85), current hypertension(AOR = 2.9, 95% CI 1.26, 6.69), fruit consumption of fewer than three servings per week(AOR = 2.64, 95% CI 1.18 to 5.92), and sedentary life(AOR = 3.33, 95% CI 1.63 to 6.79).

Conclusion

The prevalence of undiagnosed diabetes mellitus was 8.13%. Physical inactivity, family history of diabetes mellitus, current hypertension, sedentary life, and fruit servings fewer than three per week were independent predictors of undiagnosed diabetes mellitus.

Introduction

Diabetes mellitus is a group of metabolic diseases characterized by hyperglycemia resulting from defects in insulin secretion, insulin action, or both [1]. Undiagnosed diabetes mellitus (UDM) is a condition in which a person has not been diagnosed with diabetes mellitus and whose blood glucose level currently meets criteria established for the diagnosis of diabetes mellitus [2]. Undiagnosed diabetes mellitus can only be identified through a health survey, which tests a person’s blood sugar levels and asks about a history of being diagnosed with diabetes mellitus [3].

Diabetes mellitus remains a major public health problem worldwide, regardless of a country’s level of development and income. Undiagnosed DM is a challenge even in developed countries, even with universal access to healthcare and advanced healthcare technologies [4]. Globally, approximately 537 million adults between the ages of 20 and 79 will be living with DM in 2021. However, approximately half (44.7%) of them were unaware of their status [5]. Interestingly, 75% of adults who were unaware of their diabetes status are from low- and middle-income countries (LMIC) [4, 6]. In recent decades, the incidence of diabetes mellitus in Sub-Saharan Africa (SSA) has increased rapidly as a result of globalization, rapid urbanization and lifestyle changes; increased consumption of unhealthy diets and sedentary lifestyles [7].

According to a report published by the International Diabetic Federation in 2021, the proportion of undiagnosed diabetes in SSA was 54%, a 4% increase from 2019, with the African region having the highest prevalence of when compared other regions [5]. In the same year, the estimated mortality associated with DM in the African region was approximately 416,000, due to late diagnosis and failure to seek treatment [6, 8]. On the other hand, North America and the Caribbean region has the lowest proportion (37.8%) globally [8]. In Ethiopia, among populations living with diabetes, according to IDF 2017 estimate; approximately 1.96 million (76%) of them are undiagnosed and unaware of their diabetes status [9].

Besides, DM has been the leading cause of morbidity and mortality in association with numerous complications, like blindness, kidney failure, heart attacks, stroke and lower limb amputation [10, 11].

In addition to the health burden, diabetes also impacts the individual’s economy, healthcare system and government spending by incurring high medical costs. Estimated global healthcare spending related to diabetes was approximately $376 billion in 2010, accounting for approximately 12% of total healthcare spending. For these UDM reasons, an additional cost of $2864 per year per person was associated with complications related to late diagnosis and treatment [1214]. In Ethiopia, the estimated cost of NCDs is at least 31.3 billion Ethiopian birr (US$1.1 billion) per year, equivalent to about 1.8% of gross domestic product (GDP) [2]. To reduce the health and economic burden of non-communicable diseases, including diabetes mellitus, the United Nations set global goal for the reduction and prevention of non-communicable diseases, which is included in the Sustainable Development Goal(SDG) under Target 3.4, which calls for 30% reduction in premature deaths from non-communicable diseases, including diabetes mellitus, by the end of 203 [15]. To achieve this plan, global country-specific strategies have been adopted by WHO, such as improving screening, early detection and treatment for non-communicable diseases and integrating service delivery to existing health system [1519].

The Ethiopian Federal Minister of Health (FMOH) established various strategies such as: reducing key modifiable risk factors, developing and implementing legal framework, aligning the healthcare system towards person-centered care, and promoting quality research to avert the burden of NCDs in Ethiopia [20]. Despite these strategies and the availability of diagnostic screening tools, the majority of individuals come to healthcare after the disease has been progressed and multiple organ damage has occurred [21].

Factors such as educational level, body mass index, family history and the presence of other chronic illnesses have been associated with undiagnosed DM [22]. However, studies conducted in some areas of Ethiopia show varying evidence of the extent and associated factors of undiagnosed diabetes, with the extent of UDM varying between 11.5% and 2.3% [23, 24]. Apart from that, some of the studies lack information on some variables like physical activity and it is recommended to do more studies on such variables. Similarly, some of the studies also used small sample size, compromising the generalizability of the study results [25]. In addition, the evidence on undiagnosed diabetes mellitus and associated factors was limited in the study area, and some of the studies conducted on diabetes mellitus were also outdated. The results of this study will inform policymakers in developing strategies and prioritizing resource allocation, and improve community-based screening programs for early detection and improve interventions for the prevention and control of undiagnosed diabetes mellitus.

Methods and material

Study design, study area and period

A community-based cross-sectional study was conducted in Mizan-Aman town from May 23 to July 7, 2022. Mizan Aman town is the administrative center of Bench-Sheko zone, Southwest Ethiopia. The town is located 564 km from Addis Ababa, the capital city of Ethiopia. The town has an estimated population of 84,827 based on the 2007 Ethiopian Central statistical Agency projection. It has five kebeles (the least administrative unit). Regarding health facilities; currently, there are 72 governmental and private health facilities which are serving the community [26].

Study participants

All adult residents of the study area age 18 years and above were eligible to participate in the study. All adults of the selected households who fulfilled the inclusion criteria were the study populations. A randomly selected household of the selected kebele was the sampling unit and an adult age 18 years or above from a randomly selected household who actually participated in the study was the study unit. Age over 18 years old, who have lived in the study area for 6 months or more and have not been previously diagnosed with diabetes mellitus were included in the study. Critically ill individuals who were unable to communicate and respond to the questions, pregnant women and adults who were taking beta blockers within two weeks of data collection were excluded from the study.

Sample size determination and sampling technique

The sample size was determined by using single population proportion formula by using Epi info, considering the following parameter; prevalence of undiagnosed diabetes mellitus 10.2% from previous study [27], 95% confidence level, 3% margin of error, 1.5 design effect, and by adding 10% non-response rate. Then, the final sample size was 646. A multistage sampling technique was used and two kebeles (Hibret and Addis-Ketema) were randomly selected from the five kebeles in Mizan-Aman town. The sample size for each selected kebele was proportionally allocated based on the size of households in each kebele. House-holds were then identified by using a systematic random sampling technique after the sampling interval. Finally, for households with more than one eligible participant, the lottery method was used to select one study participant among those eligible household members. If a household doesn’t have any eligible residents during the initial visit, three revisits were conducted. If they were still unavailable during the three revisits, the next nearby household was chosen as a substitute. After collecting data from the substituted household, the original interval was maintained to select the next household (Fig 1).

Fig 1. Sampling procedure to study prevalence of undiagnosed diabetes mellitus and associated factors among adult residents of Mizan Aman town, 2022.

Fig 1

Data collection tools and procedure

Data was collected by four diploma nurses who were experienced in data collection procedures using a pre-tested structured interviewer-administered questionnaire. The tool is adapted from Ethiopia’s steps report on risk factors for non-communicable diseases and the prevalence of selected NCDs [28]. The questionnaire contains socio-demographic, behavioral, and biological factors. The data collection tool was initially prepared in English and translated to Amharic and then translated back to English for its consistency.

Socio-demographic and behavioral related data were collected through an interviewer administered structured questionnaire while biological related questions were collected by using pre-tested instruments. Seca mechanical weight scale was used to measure the weight, tap meter was used to measure height and waist circumferences, and CareSens N Eco digital glucometer was used to measure fasting blood glucose level of the participants. The activities were supervised by two health officers and the principal investigator throughout the data collection process.

Anthropometric measurements like weight is measured by using Seca-mechanical weighting scale to the nearest 0.1 kg after calibration, height measured in a standing position in centimeters to the nearest 1 centimeter (cm). Then body mass index (BMI) was calculated by dividing the weight by height in meter squares (h2). Then BMI ≥25 kg/m2 was classified as high and <25 kg/m2 were classified as normal [29].

Meanwhile, waist circumference was measured at a level midway between the lower rib margin and the iliac crest on the horizontal plane around the body. Then WC ≥94 cm for males and WC ≥80 cm for females was classified as high and <94 for males and <80 for females was classified as normal [30].

Regarding questionnaires related to dietary assessment, we prepared nutrition card that show of the examples of local fruits and vegetables. Each picture represents the size of servings and we asked them to answer how many days they eat fruit or vegetables in particular week, how many servings of fruit or vegetables they consume. And also we asked type of oil/fat mostly used for meal preparation.

To measure blood pressure participants were asked to sit and relax for 30 minutes before the measurement, avoid crossing their legs, keep their feet on floor, support their back, ensure an empty bladder, refrain from smoking, and abstain from consuming coffee or tea. Then the measurement was done while the participant was seated, using a digital blood pressure device on the non-dominant arm. Three readings were taken with five minutes interval between each reading, and the average of the second and the third reading was used to determine the participants’ blood pressure level.

In order to measure glucose level, participants were instructed to be on overnight fasting for at least 8 hours. Then, in the early morning of the next day; a blood sample was collected from each participant from their middle or ring finger, using CareSens N Eco digital glucometer to measure blood glucose level. Accordingly, participants who had fasting blood glucose levels of 126mg/dl or above were classified as having undiagnosed DM and those who had blood glucose measurements of 100 -125mg/dl were classified as impaired fasting glucose and those with FBS levels less than 100 mg/dl were classified as normal for blood sugar level [31]. Furthermore, participants who were diagnosed to have diabetes were informed about their disease status and were advised to visit nearby health facility for further treatment.

On the other hand, participants who were found to have impaired fasting glucose (IFG) levels and normal blood glucose levels were also counseled on risk factors of NCDs like physical inactivity, smoking, and alcohol drinking and advised to visit health care facilities for further checkup. Similarly, participants with blood glucose measurement levels <70 mg/dl were advised to have meals containing carbohydrates, fruit, and juice.

One day training was given for data collectors and supervisors on study objectives, data confidentiality, how to take blood sample and test, how to use the data collection instruments, the contents of the questionnaire in detail, and the data collection method by the principal investigator. Demonstration on measurements was conducted during training session and the trainees re-demonstrated the procedure of sample collection and physical measurements. Then, pretest was conducted on 32 (5%) of the sample in Kometa kebele. After the pretest had been conducted the results were reviewed by the principal investigator together with the data collectors and supervisors. Subsequently, some questions which were difficult or not easily understandable during the pretest were re-written in a way that the participants can easily understand and the flow of the questions was also revised and modification to the skip rule was made. The completed questionnaire was checked daily by the principal investigator for possible errors and some incomplete data were refilled by the data collectors during the next day visit for blood specimen.

Operational definition

Undiagnosed diabetes mellitus- is a condition in which participants fasting blood glucose level was 126mg/dl and above for the first time.

Physical activity- is any bodily movement produced by skeletal muscle that results in energy expenditure.

High-level physical activity: is when the calculated MET-min/week for all combinations of activities is greater or equal to 3000 MET-min per week.

Moderate level physical activity: is when the calculated MET-min/week for all combinations of activities is between 600 to 2999 MET-min per week.

Low-level physical activity: is when the calculated MET-min per week is less than 600.

Sedentary behavior: the time spent sitting at home traveling in a car, watching television, using social media, and sitting at office work.

Hypertension: an individual’s blood pressure measurement > 140/90 mmHg.

The metabolic equivalent of task-minute per week- the number of days an individual performs an activity times the time expended multiplied by the constant value for the intensity level of activity.

Fasting blood glucose level (FBS)- is the level of blood glucose measured after overnight fasting.

Current hypertension is an individual’s blood pressure measurement ≥ 140/90 mmHg in which was not previously diagnosed as hypertension.

Data analysis

The data was reviewed, coded and entered into Epi-Data v.3.1and analyzed by SPSS v.26. Data were described in terms of frequency, mean and percentage, and then presented in table and graph form. Multi-collinearity between independent variables was checked using variance inflation factor. However, no significant multi-collinearity was detected. The Hosmer-Lemeshow test of goodness fit was done to check the suitability of the model before running the final model. The statistical significance and strength of association between independent variables and an outcome variable were measured by a bi-variable logistic regression. Variables with a p-value < 0.25 in bi-variable logistic regression were transferred to multi-variable logistic regression model to adjust for confounder effect. Adjusted odds ratio with 95% confidence interval was estimated to assess the strength of the association, and statistical significance was declared at p-value < 0.05.

Ethical consideration

Ethical clearance was obtained from the Institutional Review Board (IRB) of Jimma University; with reference number IHRPD/574/22 and a formal letter of permission were secured from the respective administrative unit of the study setting. The study complies with the declaration of Helsinki and the study participants were informed of their full right to decline participation from the beginning or to quit participation at any time during the data collection process. Informed written consent was obtained from each participant. After measuring the blood glucose, participants with fasting blood glucose measurement ≥ 126 mg/dl were counseled on the control of diabetes mellitus, its complications and instructed to visit the nearby health center for further investigations and treatment. Those who have elevated blood pressure were also counseled on how to control high blood pressure and informed to visit nearby health facility.

Results

Socio-demographic and behavioral characteristics of study participants

The study comprised 627 adults, with a response rate of 97.02%. The mean age (± SD) of the participants was 37.21(± 13.5) years. More than half (56.5%) of the participants were female. Regarding educational status, 14.2% of the participants were without formal education (Table 1).

Table 1. Socio-demographic and behavioral characteristics of study participants (n = 627), Mizan-Aman town.

Variables Category Undiagnosed DM Total, N (%)
Yes, N (%) No, N (%)
Age (in years) 18–24 4 (3.1) 123 (96.9) 127 (20.3)
25–34 8 (5.3) 144 (94.7) 152 (24.2)
35–44 15 (8.8) 156 (91.2) 171 (27.3)
45–54 12 (12.6) 83 (87.4) 95 (15.2)
≥55 12 (14.6) 70 (85.4) 82 (13)
Sex Male 24 (8.8) 249 (91.2) 273 (43.5)
Female 27 (7.6) 327 (92.4) 354 (56.5)
Educational status No formal education 19(21.3) 70 (78.7) 89 (14.2)
Primary 8 (6.4) 117 (93.6) 125 (19.9)
Secondary 12 (4.7) 244 (95.3) 256 (40.8)
Diploma & above 12 (7.6) 145 (92.4) 157 (25)
Ethnicity Bench 15 (6.8) 204 (93.2) 219 (34.9)
Kaffaa 12 (9.6) 113 (90.4) 125 (19.9)
Amhara 9 (12.7) 62 (87.3) 71 (11.3)
Oromo 6 (11.8) 45 (88.2) 51 (8.1)
Gurage 2 (4.2) 46 (95.8) 48 (7.7)
Silte 2 (4.5) 42 (95.5) 44 (7)
Others* 5 (7.2) 64 (92.8) 69 (11)
Religion Protestant 20 (6.6) 283 (93.4) 303 (48.3)
Orthodox 23(10.6) 195 (89.4) 218 (34.8)
Muslim 4 (4.7) 81 (95.3) 85 (13.6)
Catholic 4 (19) 17 (81) 21 (3.3)
Marital status Single 11 (7.2) 142 (92.8) 153 (24.4)
Married 31 (7.4) 387 (92.6) 418 (66.7)
Divorce 3 (9.4) 29 (90.6) 32 (5.1)
Widowed 6 (25) 18 (75) 24 (3.8)
Occupation Merchant 11 (6.5) 159 (93.5) 170 (27.1)
Student 5 (4) 119 (96) 124 (19.8)
Housewife 11 (9.3) 107 (90.7) 118 (18.8)
Farmer 14(14.1) 85 (85.9) 99 (15.8)
Employed** 10 (8.6) 106 (91.4) 116 (18.5)
Monthly income (ETB) <1000 7 (4.9) 137 (95.1) 144 (23)
1000–1800 3 (7.7) 36 (92.3) 39 (6.2)
1801–2400 15(11.4) 117 (88.6) 132 (21)
>2400 26 (8.3) 286 (91.7) 312 (49.8)
Current smoking Yes 9(18) 41 (82) 50 (8)
No 42 (7.3) 535 (92.7) 577 (92)
Ever chew Khat Yes 16 (9.4) 154 (90.6) 170 (27.1)
No 35 (7.7) 422 (92.3) 457 (72.9)
Ever drink alcohol Yes 23 (8.8) 238 (91.2) 261 (41.6)
No 28 (7.7) 338 (92.3) 366 (58.4)
Fruit consumption (per week) <3 Servings 17(17.3) 81 (82.7) 98 (15.6)
3–4 Servings 7 (7.4) 88 (92.6) 95 (15.2)
>4 Servings 27 (6.2) 407 (93.8) 434 (69.2)
Vegetable consumption (per week) <3 Servings 9 (6.9) 122 (93.1) 131 (20.9)
3–4 Servings 8 (7.7) 96 (92.3) 104 (16.6)
>4 Servings 34 (8.7) 358 (91.3) 392 (62.5)
Physical activity (min/week) Low (<600) 28(11.2) 223 (88.8) 251 (40)
Moderate(600–2999) 18 (7.4) 226 (92.6) 244 (38.9)
High (≥3000) 5 (3.8) 127 (96.2) 132 (21)
Sedentary life (per day) <4hr 29 (9.6) 479 (90.4) 508 (81)
≥4hr 22(18.5) 97 (81.5) 119 (19)

Others* = Wolita (28), Dawuroo (19), Hadiya (13), kambata (9), ETB-Ethiopian Birr, Employed**- Government or non-government employed

Clinical characteristics and the prevalence of undiagnosed DM

Above two-thirds, (69.7%) of the participants had BMI below 25kg/m2 and about one-third (28.4%) of participants have high Waist Circumference. About one-fourth (22.3%) of the participants had a family history of diabetes mellitus and a few (9.3%) of participants had blood pressure measurements ≥140/90 mmHg (Table 2).

Table 2. Clinical characteristics and laboratory measurements of study participants.

Variables Category Undiagnosed DM Total, N (%)
Yes, N (%) No, N (%)
Ever checked blood pressure Yes 28 (12.4) 198 (83.6) 226 (36)
No 23 (5.7) 378 (94.3) 401 (64)
Ever checked blood glucose Yes 9 (9.3) 88 (90.7) 97 (15.5)
No 42 (8) 488 (92) 530 (84.5)
History of gestational DM Yes 7(1.9) 20 (5.7) 27 (7.6)
No 35 (9.9) 292(82.5) 327(92.4)
Family history of DM Yes 24 (17.1) 116 (82.9) 140 (22.3)
No 27 (5.5) 460 (94.5) 487 (77.7)
Current hypertension Yes 15 (25.9) 43 (74.1) 58 (9.3)
No 36 (6.3) 533 (93.7) 569 (90.7)
Body mass index in Kg/m2 <25 27 (6.2) 410 (93.8) 437 (69.7)
>25 24 (12.6) 166 (87.4) 190 (30.3)
Waist circumference (in cm) Normal 16 (9) 162 (91) 178 (28.4)
High 16 (9) 162 (91) 449 (71.6)

The prevalence of undiagnosed diabetes mellitus was found to be 8.1% (95% CI: 6.1 to 10.6). The study also revealed that the prevalence of pre-diabetes among study participants was, 10.5% (95% CI: 8.2–13.2) with fasting blood glucose levels of 100–125 mg/dl (Fig 2).

Fig 2. Fasting blood glucose measurement status of the study participants.

Fig 2

Factors associated with undiagnosed diabetes mellitus

In bi-variable analysis, age, educational status, marital status, occupation, monthly income, level of fruit consumption, level of physical activity, sedentary life, ever-checked blood pressure, family history of DM, body mass index, and current hypertension were found to be associated with the outcome at p<0.25. Finally, on multivariable logistic regression, family history of DM, fewer fruit consumption per week, physical inactivity and having hypertension were significantly associated with UDM at p<0.05.

In multivariable analysis participants who consumed fewer than three servings of fruits per week were 2.64 times more likely to develop undiagnosed DM as compared to participants who consumed more than four servings of fruits per week (AOR = 2.64, 95% CI 1.18, 5.92). Low physical activity was also associated with a 3.4 fold increase of undiagnosed DM as compared to high physical activity (AOR = 3.4, 95% CI: 1.08, 10.66). Compared to people who engage in a sedentary life for less than 4 hours a day, those who engage for more than 4 hours are 3.33 times more likely to have undiagnosed DM (AOR = 3.33, 95% CI: 1.63, 6.79). The odds of developing undiagnosed diabetes mellitus for those who have family history of diabetes mellitus is 2.87 as compared to those who haven’t (AOR = 2.87, 95% CI: 1.41, 5.85). Furthermore, being hypertensive was associated with a three-fold increase in undiagnosed DM as compared to being non-hypertensive, (AOR = 2.9, 95% CI: 1.26, 6.69) (Table 3).

Table 3. Factors associated with undiagnosed diabetes mellitus among adult residents of Mizan-Aman town.

Variables Undiagnosed DM COR (95% CI) AOR (95% CI) p- value
Yes N (%) No N (%)
Age(in years)
 18–24 4 (3.1) 123 (96.9) 1 1
 25–34 8 (5.3) 144 (94.7) 1.71 (0.05, 5.81) 1.78 (0.4, 7.99) 0.454
 35–44 15 (8.8) 156 (91.2) 2.96 (0.96, 9.13) 3.47 (0.75, 15.97) 0.110
 45–54 12 (12.6) 83 (87.4) 4.45 (1.39, 14.26) 4.25 (0.8, 22.48) 0.089
 ≥55 12 (14.6) 70 (85.4) 5.27 (1.64, 16) 3.97 (0.72, 21.83) 0.113
Educational status
 No formal education 19 (21.3) 70 (78.7) 1 1
 Primary 8 (6.4) 117 (93.6) 0.25 (0.11, 0.61) 0.41 (0.14, 1.22) 0.109
 Secondary 12 (4.7) 244 (95.3) 0.18 (0.08, 0.39) 0.44 (0.15, 1.33) 0.147
 Diploma & above 12 (7.6) 145 (92.4) 0.30 (0.14, 0.66) 0.5 (0.12, 2.07) 0.342
Marital status
 Single 11 (7.2) 142 (92.8) 1 1
 Married 31 (7.4) 387 (92.6) 1.03 (0.51, 2.11) 0.38 (0.14, 1.02) 0.056
 Divorce 3 (9.4) 29 (90.6) 1.34 (0.35, 5.09) 0.52 (0.1, 2.82) 0.451
 Widowed 6 (25) 18 (75) 4.3 (1.42, 13.04) 0.37 (0.07, 1.88) 0.231
Occupation
 Merchant 11 (6.5) 159 (93.5) 0.73(0.3, 1.79) 0.68 (0.18, 2.53) 0.561
 Student 5 (4) 119 (96) 0.45 (0.15, 1.35) 0.64 (0.13, 3.13) 0.580
 Housewife 11 (9.3) 107 (90.7) 1.09 (0.15, 1.35) 1.24 (0.28, 5.6) 0.778
 Farmer 14 (14.1) 85 (85.9) 1.75 (0.74, 4.13) 0.9 (0.2, 4.06) 0.885
 Employee 10 (8.6) 106 (91.4) 1 1
Monthly income (ETB)
 <1000 7 (4.9) 137 (95.1) 1 1
 1000–1800 3 (7.7) 36 (92.3) 1.63 (0.4, 6.6) 0.71 (0.13, 3.72) 0.682
 1801–2400 15 (11.4) 117 (88.6) 2.51 (1, 6.36) 3.19 (0.97, 10.46) 0.056
 >2400 26 (8.3) 286 (91.7) 1.78 (0.75, 4.2) 1.41 (0.45, 4.4) 0.555
Current smoking
 Yes 9(18) 41 (82) 2.79 (1.27, 6.14) 1.72 (0.64, 4.57) 0.281
 No 42 (7.3) 535 (92.7) 1 1
Fruit consumption (per week)
 <3 Servings 17 (17.3) 81 (82.7) 3.16 (1.65,6.07) 2.64 (1.18, 5.92) * 0.018
 3–4 Servings 7 (7.4) 88 (92.6) 1.2 (0.51, 2.84) 1.3 (0.49, 3.48) 0.600
 >4 Servings 27 (6.2) 407 (93.8) 1 1
Physical activity
 Low (<600) 28 (11.2) 223 (88.8) 3.19 (1.2, 8.47) 3.4 (1.08, 10.66) ** 0.037
 Moderate (600–2999) 18 (7.4) 226 (92.6) 2.02 (0.73, 5.58) 2.61 (0.81, 8.41) 0.109
 High (≥3000) 5 (3.8) 127 (96.2) 1 1
Sedentary life
 ≥4hr per day 22 (18.5) 97 (81.5) 3.75 (2.1, 6.8) 3.33 (1.63, 6.79) * 0.001
 <4hr per day 29 (9.6) 479 (90.4) 1 1
Ever checked BP
 Yes 28 (12.4) 198 (83.6) 1.18 (0.39, 1.79) 1.66 (0.84, 3.3) 0.149
 No 23 (5.7) 378 (94.3) 1 1
Family history of DM
 Yes 24 (17.1) 116 (82.9) 3.52 (1.96, 6.34) 2.87 (1.41, 5.85) * 0.004
 No 27 (5.5) 460 (94.5) 1 1
Body mass index
 ≥25 24 (12.6) 166 (87.4) 2.19 (1.23, 3.92) 2.01 (0.99, 4.1) 0.053
 <25 27 (6.2) 410 (93.8) 1 1
Current hypertension
 Yes 15 (25.9) 43 (74.1) 5.16 (2.62, 10.17) 2.9 (1.26, 6.69) * 0.012
 No 36 (6.3) 533 (93.7) 1 1

*Significant at p < 0.05, BP-Blood Pressure, 1- Reference, COR-Crude odds ratio, AOR- adjusted odds ratio

Discussion

The study aimed to assess prevalence of undiagnosed diabetes mellitus and associated factors among adult population in Mizan Aman town, southwestern Ethiopia. Our study found that the prevalence of undiagnosed DM was 8.13%. The finding is comparable to study conducted in Bahir-dar(10.2%), Dire-Dawa(6.2%), Africa(8.84%), Malaysia(8.9%) and Germany(8.2%) [27, 3236]. However, it is higher than the study results of Jimma, Bishoftu, Koladiba, Iran, Qatar [24, 25, 3740]. The possible explanation might be difference in sociocultural, healthcare infrastructure, and community awareness related to routine NCD screening. For example; Koladiba’s study included rural populations, which are characteristically different from urban populations in terms of risk factors, and some of the studies used small sample sizes [24]. The other possible explanation for the above difference in prevalence is that urban areas in developing countries are currently undergoing a dietary shift towards more unhealthy consumption and junk food, a change in work patterns from heavy work and a Western lifestyle that Need implies more effort in community awareness and education about healthy lifestyles [41].

On the other hand, the prevalence of undiagnosed DM in this study was lower than results of East Gojjam(11.5%), Metu(12.3%), Iraq (11%), Tamil Nadu(11.1%),Urban areas of Egypt (20%) [23, 39, 4244]. These difference in prevalence might be possibly associated with socio-cultural characteristics, lifestyles, healthcare-seeking behavior, and health infrastructures [45]. Concerning the associated factors, the majority of the factors associated with undiagnosed DM in the current study were modifiable risk factors. Undiagnosed diabetes mellitus was more common in participants with low physical activity (< 600 MET-min per week). This was consistent with findings from Qatar, Jimma, South Africa, Kenya and a study in Ethiopia on risk factors for non-communicable diseases [25, 40, 4648]. The impact of physical activity on reducing the risk of developing undiagnosed diabetes is clear because, during physical activity, glucose uptake into active muscles increases by increasing insulin sensitivity and allowing muscle cells to use glucose efficiently.

Physical activity combined with moderate weight loss has been shown to reduce the risk of type 2 DM by up to 58% in high-risk populations [44]. The study also found that adults who led a sedentary lifestyle were more likely to develop UDM than their peers. The result was consistent with study done in East Gojjam, Jimma town, Mettu town and Brazil respectively [23, 25, 42, 49]. Sedentary lifestyle leading to reduced peripheral insulin-mediated glucose uptake, which secondarily leads to glucose resistance caused by reduced sensitivity of muscle cells, implying that the risk of undiagnosed diabetes mellitus can be minimized by adopting sedentary lifestyle is avoided [49].

This study also found that participants with a family history of diabetes mellitus had higher risk of developing undiagnosed DM than their counterpart, which was consistent with studies done in East Gojjam, Jimma town, Bahir Dar city, Uganda and Northern Sudan respectively [23, 25, 27, 5054]. According our study, people with hypertension (blood pressure > 140/90 mmHg) are more likely to have undetected diabetes mellitus than participants with normotensive. This result is consistent with study results from East Gojjam, Nekemte town, Bishoftu town, Malaysia and Indonesia respectively [23, 3537, 55]. The possible explanation is that, in type 2 diabetes mellitus there is body resistance to the insulin, which causes sugar to build up in the blood, leading to damage to the small blood vessels in the body, causing the walls of the blood vessels to become stiff and increasing blood pressure. The other mechanism is that, insulin resistance-induced hyperinsulinemia and hyperglycemia occur in DM patients, which increase systemic blood pressure [56].

Finally, our study found that participants who consumed fewer than 3 servings of fruits per week were at higher risk of developing undetected diabetes mellitus than those who consumed more than four servings per week which is consistent with a study conducted in china [57]. Fruits and vegetables are fiber-rich in nature which plays an important role in decreasing serum cholesterol and decreasing the release of sugar into the blood which leads to the decrease of blood glucose in the blood by nearly 40% [58]. The World Health Organization (WHO) has recommended that a person should eat 400g of fruit, or five servings of fruit and vegetables, per day [59].

On the contrary, in some studies conducted in another part of Ethiopia, it was found that there was no significant association between fruit consumption and undiagnosed diabetes mellitus, which could be due to the different availability of fresh fruits and vegetables in the two study areas. Portion measurement in developing countries is somewhat challenging [34]. On the other hand, factors such as age, gender, marital status, smoking, glycemic control, and gestational diabetes were not significantly associated with undiagnosed diabetes mellitus, although they were significant in other previously conducted studies. A possible explanation for the difference could be the number of differences between the participants with the characteristics of the difference in the previous study and our study. For example, fewer study participants smoked in our study than in other studies [23].

Strengths and limitations of the study

This study was community based with reasonable sample size and employed probability sampling and tried to include various variables which were not included in previous studies. However, the study was subject to recall bias and social desirability bias for some behavior-related factors such as smoking, Khat chewing, and alcohol consumption. Furthermore, lipid profile is not included to this study due to resource limitation.

Conclusion and recommendations

The magnitude of undiagnosed DM in the study area was higher than the national pooled prevalence of UDM in Ethiopia. Physical inactivity, sedentary life, family history of diabetes, hypertension, and low level of fruit consumption were the factors associated with undiagnosed DM. Most of the associated factors in this study were modifiable risk factors and can be solved through creating community awareness and community-based interventional activities. Efforts should be made by politicians, decision makers and other healthy institutions to implement screening modality and early interventions and finally we suggest for future researcher to include other biochemical measurements like lipid profiles and specifically other blood glucose tests.

Supporting information

S1 Checklist. STROBE statement—Checklist of items that should be included in reports of observational studies.

(DOCX)

pone.0302167.s001.docx (44.4KB, docx)
S1 File

(DOCX)

pone.0302167.s002.docx (48.1KB, docx)
S2 File

(DOCX)

pone.0302167.s003.docx (40KB, docx)
S1 Data

(SAV)

pone.0302167.s004.sav (199.7KB, sav)

Acknowledgments

The author is grateful to the participants of the study who shared their time to give their genuine responses, data collectors and supervisor.

Abbreviations

AOR

Adjusted Odds Ratio

BMI

Body Mass Index

COR

Crude Odds Ratio

CSA

Central Statistical Agency

DM

Diabetes Mellitus

IDF

International Diabetic Federation

SPSS

Statistical Package for Social Science

SSA

Sub-Saharan Africa

UDM

Undiagnosed Diabetes Mellitus

WC

Waist Circumference

WHO

World Health Organization

Data Availability

All relevant data are within the paper and its Supporting information files.

Funding Statement

The author(s) received no specific funding for this work.

References

  • 1.World Health Organisation (WHO), “Diabetes Mellitus and Other Categories of Description of Diabetes,” World Health, vol. 28, no. Suppl 1, p. 224102, 2005 [Google Scholar]
  • 2.Zhang Y. et al., “The economic costs of undiagnosed diabetes,” Popul. Health Manag., vol. 12, no. 2, pp. 95–101, 2009, doi: 10.1089/pop.2009.12202 [DOI] [PubMed] [Google Scholar]
  • 3.Young T. K. and Mustard C. A., “Undiagnosed diabetes: Does it matter?,” vol. 164, no. 1, pp. 6–10, 2001. [PMC free article] [PubMed] [Google Scholar]
  • 4.IDF, IDF Diabetes Atlas 6th. 2021.
  • 5.Ogurtsova K. et al., “IDF diabetes Atlas: Global estimates of undiagnosed diabetes in adults for 2021,” Diabetes Res. Clin. Pract., vol. 183, Jan. 2022, doi: 10.1016/j.diabres.2021.109118 [DOI] [PubMed] [Google Scholar]
  • 6.Saeedi P. et al., “Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9th edition,” Diabetes Res. Clin. Pract., vol. 157, p. 107843, 2019, doi: 10.1016/j.diabres.2019.107843 [DOI] [PubMed] [Google Scholar]
  • 7.Coles E. and Mensah G. A., “The Burden of Heart, Lung, and Blood Diseases in the United States, 1990 to 2016: Perspectives from the National Heart, Lung, and Blood Institute,” Glob. Heart, vol. 12, no. 4, pp. 349–358, 2017, doi: 10.1016/j.gheart.2017.11.001 [DOI] [PubMed] [Google Scholar]
  • 8.Ogurtsova K. et al., “IDF diabetes Atlas: Global estimates of undiagnosed diabetes in adults for 2021,” Diabetes Res. Clin. Pract., vol. 183, p. 109118, Jan. 2022, doi: 10.1016/j.diabres.2021.109118 [DOI] [PubMed] [Google Scholar]
  • 9.N. H. (chair) et al. Cho, Eighth Edition 2017. 2017. [Online]. https://www.idf.org/aboutdiabetes/type-2-diabetes.html
  • 10.Cortez D. N., Reis I. A., Souza D. A. S., Macedo M. M. L., and De Carvalho Torres H., “Complications and the time of diagnosis of diabetes mellitus in primary care,” ACTA Paul. Enferm., vol. 28, no. 3, pp. 250–255, 2015, doi: 10.1590/1982-0194201500042 [DOI] [Google Scholar]
  • 11.Skeldon S. C., Detsky A. S., Goldenberg S. L., and Law M. R., “Erectile dysfunction and undiagnosed diabetes, hypertension, and hypercholesterolemia,” Ann. Fam. Med., vol. 13, no. 4, pp. 331–335, 2015, doi: 10.1370/afm.1816 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Asmelash D. and Asmelash Y., “The burden of undiagnosed diabetes mellitus in adult african population: A systematic review and meta-analysis,” J. Diabetes Res., vol. 2019, 2019, doi: 10.1155/2019/4134937 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Zhang P. et al., “Global healthcare expenditure on diabetes for 2010 and 2030,” Diabetes Res. Clin. Pract., vol. 87, no. 3, pp. 293–301, 2010, doi: 10.1016/j.diabres.2010.01.026 [DOI] [PubMed] [Google Scholar]
  • 14.Al-Maskari F., El-Sadig M., and Nagelkerke N., “Assessment of the direct medical costs of diabetes mellitus and its complications in the United Arab Emirates,” BMC Public Health, vol. 10, pp. 1–10, 2010, doi: 10.1186/1471-2458-10-679 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.R. B. Johnston, “2030 Agenda for sustainable development,” Arsen. Res. Glob. Sustain.—Proc. 6th Int. Congr. Arsen. Environ. AS 2016, pp. 12–14, 2016.
  • 16.“Noncommunicable diseases.” Accessed: Mar. 07, 2022. [Online]. https://www.who.int/teams/surveillance-of-noncommunicable-diseases/about/ncds
  • 17.World Health Organization, “Prevention and control of noncommunicable diseases: implementation of the global strategy Report by the Secretariat- Sixty-First World Health Assembly,” World Heal. Assem., no. April 2009, pp. 1–21, 2010, [Online]. http://apps.who.int/gb/ebwha/pdf_files/A61/A61_8-en.pdf?ua=1
  • 18.WHO, Draft Updated Appendix 3 To the Global Action Plan for the Prevention and Control of Noncommunicable Diseases 2013–2020, vol. 300, no. October 2016. 2017. [Online]. http://apps.who.int/gb/ebwha/pdf_files/EB140/B140_27-en.pdf?ua=1%0Ahttp://apps.who.int/gb/ebwha/pdf_files/EB140/B140_27-en.pdf
  • 19.WHO, “Monitoring noncommunicable disease commitments in Europe,” World Heal. Organ., 2017, [Online]. https://www.euro.who.int/__data/assets/pdf_file/0005/351518/Monitoring-NCD.pdf?ua=1
  • 20.FMOH, “Ethiopian Health Sector Transformation Plan.2015/16–2019/20,” Fed. Democr. Repub. Ethiop. Minist. Heal., vol. 20, no. May, p. 50, 2015.
  • 21.Vladislav Dombrovskiy, A. Workneh, F. Shiferaw, R. Small, and N. Banatvala, “Prevention and control of noncommunicable diseases in Ethiopia: The case for investment, including considerations on the impact of khat,” 2019.
  • 22.Ismail H., Omar A., Aris T., Ambak R., Hisham A. A. N., and Lim K. K., “Undiagnosed Type 2 Diabetes Mellitus and Its Risk Factors Among Malaysians: National Health and Morbidity Survey, 2011,” Int. J. Public Health, vol. 6, no. 1, pp. 677–684, 2016, [Online]. Available: http://spaj.ukm.my/ijphr/index.php/ijphr/article/view/41 [Google Scholar]
  • 23.Wondemagegn A. T. et al., “Undiagnosed diabetes mellitus and related factors in East Gojjam (NW Ethiopia) in 2016: a community-based study,” vol. 6, pp. 4–9, 2017. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Worede A., Alemu S., Gelaw Y. A., and Abebe M., “The prevalence of impaired fasting glucose and undiagnosed diabetes mellitus and associated risk factors among adults living in a rural Koladiba town, northwest Ethiopia,” BMC Res. Notes, vol. 10, no. 1, pp. 1–7, 2017, doi: 10.1186/s13104-017-2571-3 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Yunka T. T. et al., “The hidden burden of diabetes mellitus in an urban community of southwest ethiopia,” Diabetes, Metab. Syndr. Obes. Targets Ther., vol. 13, pp. 2925–2933, 2020, doi: 10.2147/DMSO.S269386 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.“S/N/N/P/R/Government Bench Sheko Zone Health Department, Mizan Aman Health Office 2014 plan, June, 2013.”
  • 27.Bantie G. M. et al., “Prevalence of undiagnosed diabetes mellitus and associated factors among adult residents of Bahir Dar city, northwest Ethiopia: a community-based cross-sectional study,” BMJ Open, vol. 9, no. 10, pp. 1–7, 2019, doi: 10.1136/bmjopen-2019-030158 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Richters C. D. et al., “The cellular composition in the peritoneal cavity and the cytotoxic function of the peritoneal cells from patients with ovarian cancer; effect of tumor necrosis factor-α treatment,” Cancer Lett., vol. 68, no. 1, pp. 25–31, 1993, doi: 10.1016/0304-3835(93)90215-U [DOI] [PubMed] [Google Scholar]
  • 29.C. B. Weir and A. Jan, “BMI Classification Percentile And Cut Off Points,” StatPearls, no. November, 2019, [Online]. http://www.ncbi.nlm.nih.gov/pubmed/31082114 [PubMed]
  • 30.Owolabi E. O., Ter Goon D., Adeniyi O. V., and Ajayi A. I., “Optimal waist circumference cut-off points for predicting metabolic syndrome among low-income black South African adults,” BMC Res. Notes, vol. 11, no. 1, pp. 1–5, 2018, doi: 10.1186/s13104-018-3136-9 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Freedman R. B., “Membrane-bound enzymes,” New Compr. Biochem., vol. 1, no. C, pp. 161–214, 1981, doi: 10.1016/S0167-7306(09)60009-0 [DOI] [Google Scholar]
  • 32.Rathmann W. et al., “High prevalence of undiagnosed diabetes mellitus in Southern Germany: Target populations for efficient screening. The KORA survey 2000,” Diabetologia, vol. 46, no. 2, pp. 182–189, 2003, doi: 10.1007/s00125-002-1025-0 [DOI] [PubMed] [Google Scholar]
  • 33.Dessie G. et al., “A systematic analysis on prevalence and sub-regional distribution of undiagnosed diabetes mellitus among adults in African countries,” J. Diabetes Metab. Disord., vol. 19, no. 2, pp. 1931–1941, 2020, doi: 10.1007/s40200-020-00635-9 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Ayele B. H., Roba H. S., Beyene A. S., and Mengesha M. M., “Prevalent, uncontrolled, and undiagnosed diabetes mellitus among urban adults in Dire Dawa, Eastern Ethiopia: A population-based cross-sectional study,” SAGE Open Med., vol. 8, p. 205031212097523, 2020, doi: 10.1177/2050312120975235 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Alemu A., Dessalegn T., and Tefera B., “Magnitude of undiagnosed diabetes mellitus and Associated Factors among Middle Aged Urban Residents of West Ethiopia,” J. Obes. Weight. Medicat., vol. 7, no. 1, pp. 1–10, 2021 [Google Scholar]
  • 36.Ismail H., Omar M. A., Aqilah A., Hisham N., Aris T., and Ambak R., “Undiagnosed Type 2 Diabetes Mellitus and Its Risk Factors Among Malaysians: National Health and Morbidity Survey, 2011,” Int. J. Public Heal. Res., vol. 6, no. 1, pp. 677–684, 2016. [Google Scholar]
  • 37.Mistire Wolde Gebre Y. C. M. and Ahmed Raja Goshu S. K. B., “Prevalence of Undiagnosed Diabetes Mellitus and its Risk Factors in Selected Institutions at Bishoftu Town, East Shoa, Ethiopia,” J. Diabetes Metab., pp. 1–7, 2013, doi: 10.4172/2155-6156.s12-00824567847 [DOI] [Google Scholar]
  • 38.Yitbarek G. Y. et al., “Undiagnosed diabetes mellitus and associated factors among adults in Ethiopia: a systematic review and meta-analysis,” Sci. Rep., vol. 11, no. 1, pp. 1–10, 2021, doi: 10.1038/s41598-021-03669-y [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Mansour A. A., Al-Maliky A. A., Kasem B., Jabar A., and Mosbeh K. A., “Prevalence of diagnosed and undiagnosed diabetes mellitus in adults aged 19 years and older in Basrah, Iraq,” Diabetes, Metab. Syndr. Obes. Targets Ther., vol. 7, no. May 2014, pp. 139–144, 2014, doi: 10.2147/DMSO.S59652 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Bener A., Zirie M., Janahi I. M., Al-Hamaq A. O. A. A., Musallam M., and Wareham N. J., “Prevalence of diagnosed and undiagnosed diabetes mellitus and its risk factors in a population-based study of Qatar,” Diabetes Res. Clin. Pract., vol. 84, no. 1, pp. 99–106, 2009, doi: 10.1016/j.diabres.2009.02.003 [DOI] [PubMed] [Google Scholar]
  • 41.A. Now and R. Course, “The Growing Danger of Non-Communicable Diseases Acting Now to Reverse Course,” no. September, 2011.
  • 42.Zenu S. and Reshad M., “Prevalence of Undiagnosed Diabetes Mellitus and Associated Factors in Adults in Mettu Town, Southwest Ethiopia: Community Based Cross Sectional Study,” vol. 4, no. 2, pp. 1–6, 2022. [Google Scholar]
  • 43.Subramani R. et al., “Prevalence of Undiagnosed Type 2 Diabetes and its Associated Risk Factors in Rural Population of Tamil Nadu,” World J. Med. Sci., vol. 11, no. 2, pp. 222–227, 2014, doi: 10.5829/idosi.wjms.2014.11.2.84252 [DOI] [Google Scholar]
  • 44.Herman W. H., Aubert R. E., Ali M. A., Sous E. S., and Badran A., “Diabetes mellitus in Egypt: Risk factors, prevalence and future burden,” Eastern Mediterranean Health Journal, vol. 3, no. 1. pp. 144–148, 1997. doi: 10.26719/1997.3.1.144 [DOI] [Google Scholar]
  • 45.Pastakia S. D., Pekny C. R., Manyara S. M., and Fischer L., “Diabetes in sub-Saharan Africa—from policy to practice to progress: Targeting the existing gaps for future care for diabetes,” Diabetes, Metab. Syndr. Obes. Targets Ther., vol. 10, pp. 247–263, 2017, doi: 10.2147/DMSO.S126314 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46.Colberg S. R. et al., “Exercise and type 2 diabetes: The American College of Sports Medicine and the American Diabetes Association: Joint position statement,” Diabetes Care, vol. 33, no. 12, 2010, doi: 10.2337/dc10-9990 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47.Levitt N. S. et al., “Modifiable risk factors for Type 2 diabetes mellitus in a peri-urban community in South Africa,” Diabet. Med., vol. 16, no. 11, pp. 946–950, 1999, doi: 10.1046/j.1464-5491.1999.00185.x [DOI] [PubMed] [Google Scholar]
  • 48.Yarinbab T. E., Ahmed S. I., and Alemseged F., “Prevalence and Determinants of Modifiable Risk Factors for Chronic Non-Communicable Diseases among Adults in Mizan-Aman Town, Ethiopia: A Community Based Cross Sectional Study,” Juniper Online J. Public Heal., vol. 3, no. 5, pp. 1–9, Jun. 2018, doi: 10.19080/JOJPH.2018.03.555622 [DOI] [Google Scholar]
  • 49.Da Silva R. D. C. et al., “Association between time spent sitting and diabetes mellitus in older adults: A population-based study,” Rev. Bras. Cineantropometria e Desempenho Hum., vol. 17, no. 4, pp. 379–388, 2015 [Google Scholar]
  • 50.Mutebi E., Nakwagala F. N., Nambuya A., and Otim M., “Diabetes 2 in Uganda,” vol. 20, no. 1, 2012. [Google Scholar]
  • 51.Aekplakorn W. et al., “A risk score for predicting incident diabetes in the Thai population,” Diabetes Care, vol. 29, no. 8, pp. 1872–1877, 2006, doi: 10.2337/dc05-2141 [DOI] [PubMed] [Google Scholar]
  • 52.Zein C. O., Sc M., Levy C., Basu A., and Zein N. N., “Chronic Hepatitis C and Type II Diabetes Mellitus: A Prospective Cross-Sectional Study,” no. i, 2005, doi: 10.1111/j.1572-0241.2005.40429.x [DOI] [PubMed] [Google Scholar]
  • 53.Rouabhia S., Malek R., Bounecer H., Dekaken A., Amor F. B., and Sadelaoud M., “Prevalence of type 2 diabetes in Algerian patients with hepatitis C virus infection,” vol. 16, no. 27, pp. 3427–3431, 2010, doi: 10.3748/wjg.v16.i27.3427 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 54.Elbagir M. N., Eltom M. A., Elmahadi E. M. A., Kadam I. M. S., and Berne C., “A high prevalence of diabetes mellitus and impaired glucose tolerance in the Danagla community in Northern Sudan,” Diabet. Med., vol. 15, no. 2, pp. 164–169, 1998, doi: [DOI] [PubMed] [Google Scholar]
  • 55.Pramono L. A. et al., “Prevalence and predictors of undiagnosed diabetes mellitus in Indonesia.,” Acta Med. Indones., vol. 42, no. 4, pp. 216–223, 2010. [PubMed] [Google Scholar]
  • 56.Ohishi M., “Hypertension with diabetes mellitus: physiology and pathology,” Hypertens. Res. 2018 416, vol. 41, no. 6, pp. 389–393, Mar. 2018, doi: 10.1038/s41440-018-0034-4 [DOI] [PubMed] [Google Scholar]
  • 57.Du H, Li L, Bennett D, Guo Y, Turnbull I, and Yang L, “Fresh fruit consumption in relation to incident diabetes and diabetic vascular complications. PLoS Med [revista en Internet] 2017 [acceso 2 de noviembre de 2021]; 14(4): 1–19.,” vol. 300, pp. 1–19, 2017, [Online]. https://journals.plos.org/plosmedicine/article?id=10.1371/journal.pmed.1002279 [DOI] [PMC free article] [PubMed]
  • 58.Liu R. H., “Health-promoting components of fruits and vegetables in the diet,” Adv. Nutr., vol. 4, no. 3, 2013, doi: 10.3945/an.112.003517 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 59.“Healthy diet.” Accessed: Jul. 28, 2022. [Online]. https://www.who.int/news-room/fact-sheets/detail/healthy-diet

Decision Letter 0

Mohammed Hasen Badeso

29 Dec 2023

PONE-D-23-12386Prevalence of undiagnosed diabetes mellitus and associated factors among adult residents of Mizan Aman town, Southwest Ethiopia: Community-based cross-sectional studyPLOS ONE

Dear Dr. Kune,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript by Feb 12 2024 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Mohammed Hasen Badeso, MPH in Field Epidemiology

Academic Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf.

2. Did you know that depositing data in a repository is associated with up to a 25% citation advantage (https://doi.org/10.1371/journal.pone.0230416)? If you’ve not already done so, consider depositing your raw data in a repository to ensure your work is read, appreciated and cited by the largest possible audience. You’ll also earn an Accessible Data icon on your published paper if you deposit your data in any participating repository (https://plos.org/open-science/open-data/#accessible-data).

3. We note that this data set consists of interview transcripts. Can you please confirm that all participants gave consent for interview transcript to be published?

If they DID provide consent for these transcripts to be published, please also confirm that the transcripts do not contain any potentially identifying information (or let us know if the participants consented to having their personal details published and made publicly available). We consider the following details to be identifying information:

- Names, nicknames, and initials

- Age more specific than round numbers

- GPS coordinates, physical addresses, IP addresses, email addresses

- Information in small sample sizes (e.g. 40 students from X class in X year at X university)

- Specific dates (e.g. visit dates, interview dates)

- ID numbers

Or, if the participants DID NOT provide consent for these transcripts to be published:

- Provide a de-identified version of the data or excerpts of interview responses

- Provide information regarding how these transcripts can be accessed by researchers who meet the criteria for access to confidential data, including:

a) the grounds for restriction

b) the name of the ethics committee, Institutional Review Board, or third-party organization that is imposing sharing restrictions on the data

c) a non-author, institutional point of contact that is able to field data access queries, in the interest of maintaining long-term data accessibility.

d) Any relevant data set names, URLs, DOIs, etc. that an independent researcher would need in order to request your minimal data set.

For further information on sharing data that contains sensitive participant information, please see: https://journals.plos.org/plosone/s/data-availability#loc-human-research-participant-data-and-other-sensitive-data

If there are ethical, legal, or third-party restrictions upon your dataset, you must provide all of the following details (https://journals.plos.org/plosone/s/data-availability#loc-acceptable-data-access-restrictions):

a. A complete description of the dataset

b. The nature of the restrictions upon the data (ethical, legal, or owned by a third party) and the reasoning behind them

c The full name of the body imposing the restrictions upon your dataset (ethics committee, institution, data access committee, etc)

4. If the data are owned by a third party, confirmation of whether the authors received any special privileges in accessing the data that other researchers would not have

5. Direct, non-author contact information (preferably email) for the body imposing the restrictions upon the data, to which data access requests can be sent

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: No

Reviewer #3: Partly

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: No

Reviewer #3: Yes

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: No

Reviewer #2: No

Reviewer #3: No

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: Prevalence of undiagnosed diabetes mellitus and associated factors among adult residents of Mizan Aman town, Southwest Ethiopia: Community-based cross-sectional study

Thank you very much for giving me the opportunity to review this well written Manuscript

From the introduction part of the abstract section: You should show why you are going to conduct this study? Is it a public health concern?

What is WHO STEP wise method? Is it a tool? If so, determine its validity and reliability? The information present in the abstract should be present the main document. But this information/statement is not found in the main document.

Why did you use fasting blood glucose level to determine whether the individual has diabetes mellitus or not? Why did you fail to use either random blood glucose or OGTT?

Did you think that only single measurement of blood glucose is sufficient to declare whether the patient has diabetes mellitus or not? How do you exclude those risk factors which may elevate blood glucose level?

Did you think that only single measurement of blood pressure is sufficient to declare whether the patient has hypertension or not? How do you exclude those risk factors which may elevate blood pressure level?

Could you explain the entire procedure to measure random blood glucose level? How do you know, if the person eats breakfast and he said that he is fasting for more than 8 hour? How do you detect such types of error/bias? How do you detect measurement error? Do you know the sensitivity and specificity of the measurement tool?

Why do you focus on the prevalence of undiagnosed DM among adult people? Did you think that, it is not common in pediatrics age group? Or DM is not a concern for pediatrics population?

As you stated in the introduction section, despite different strategies were undertaken to reduce the incidence of DM, the majority of individuals come to healthcare after the disease has been progressed and multiple organ damage has occurred. So, it is better to study why people fail to measure/to be measured their blood glucose level regularly? As per my understanding, the effect of undiagnosed DM is not mentioned.

Why you are going to conduct this study, since it is studied and published in the different regions and corners of the country? You just tried to justify under the last paragraph of the introduction section but it is not persuasive as intended.

What is your inclusion criterion?

Why did you exclude pregnant women and adults who were taking beta blockers within two weeks of data collection?

Why did you use 3% margin of error, and 1.5 design effect?

The sampling procedure is not well explained. So it needs revision and it is recommended to support using diagrammatic presentation. In the case of households with no eligible participant at the time of visit, the next nearby household was selected as a substitute why you fail to revisit?

The tool is adapted from Ethiopia's steps report on risk factors for non-communicable diseases and the prevalence of selected NCDs (25)……it is not similar with the idea stated under reference 25. So. It needs revision. Similarly see reference number 28

Could you explain about the specificity and sensitivity of CareSens TM N Eco digital glucometer?

Why did you select those variables with a p-value < 0.25 in bi-variable logistic regression transferred to multi-variable logistic regression model to adjust for confounder effect? What is your evidence and justification???

What is the declaration of Helsinki? How did you get blood sample? Did the study participants were volunteer? Could you tell me any event you experienced while collecting blood from the people? Did they ask any compensation for the harm? Please explain each ethical standard.

How do you classify monthly income in to these categories? Did you have any evidence? If so what is your evidence?

In bi-variable analysis, 12 variables were identified as statistically significant variable……..it is not necessary to mention the number rather it is enough to mention the variable solely.

Why did you fail to interpret each and every variable’s which had statistically significant association with the outcome variable? Please interpret each variable

Some terminology needs operational definition. Eg sedentary life

In the discussion section, you write reference number rather than writing the study setting/area. Please write the specific area/town/country and some justification given for the possible association is not persuasive. So it needs revision.

Your strength of the study is not ideal

Reviewer #2: � There are grammatical and syntax errors throughout the manuscript. The manuscript needs extensive review by the author and should also be checked by a professional speaker of English.

� Please write abbreviations in full at the first time of use.

� The objectives and rationale of the study are not clearly stated. Why not include impaired fasting sugar level, or pre-DM, and its risk factors in your study? Previously, almost similar studies had been conducted in the same study area, so what is the significance of doing this study?

� Abstract:

� Background: In the background part, include the problem or identified gap that you want to fill.

� Methods: Please include the laboratory method that you used to determine the fasting blood sugar level briefly.

� Avoid abbreviations from the abstract.

� Introduction: Add information about the complications and risk factors of DM. Some literature is not up-to-date and needs to be reviewed properly.

� Methods and materials:

� The sampling technique is not well stated. How many households were in each cluster? How was the selection made? Please include the detailed sampling frame.

� How can you be sure that patients were fasting overnight? Is there any system used to convince them and trust them?

� Add relevant citations for important statements.

� Quality control measures are inadequate. What quality control measures were you using for the CareSensTM N Eco digital glucometer to ensure the method was safe?

� Please operationally define physical activity, sedentary life, hypertension, undiagnosed DM, and so on.

� Ethical consideration: What was done for those with raised blood pressure?

� Results:

� The presentation of the results is poor in terms of sentence form, coherence, outcome measurement, and lots of grammatical errors. The authors are unable to provide the most important result in a short and precise manner. Furthermore, the results are simply summarized in the tables without sufficient explanation. In general, the results section needs major modification.

� The authors did not include some important variables, such as lipid profile, in their study.

� Diagrams and figures are missing. Add figures and diagrams.

� The study has many more limitations, but the authors did not include them as the limitations of the study.

Reviewer #3: General comment

The author tried to estimate the prevalence of undiagnosed DM and its predictors among residents of Mizan Aman town. However, the predictive variables such as hypertension, family Hx, sedentary life, and physical activity are the very well known risk factors for DM. So what value this research could add to the scientific world. This is the major gap of the study.

Introduction

Most of the sentences in this section are not paraphrased by the authors own word. For instance the first sentence is directly copied from somewhere. So the authors have to re-write the sentences by their own word.

Methods

Why adults taking beta blockers are excluded from the study?

The tools the author used for dietary questions should be described in detail

Some terms like ever drinker/chewer, current chewer/drinker, and physical activity should be operationally defined.

Result

In table 2, there is a variable “history of gestational diabetes”. I think this variable should be only for female participants. But the authors used it for both males and females. How?

In table 3, the P-value for COR should be stated.

Discussion and conclusion

Being community based study by itself cannot be the strength of your study. There are an ample community based studies conducted on undiagnosed DM among residents of Ethiopia.

The conclusion and recommendation part is very weak. There is no direction toward future studies, emphasis on what needs to be done, or what is missing.

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

Reviewer #3: Yes: Misganaw Asmamaw Mengstie

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

Attachment

Submitted filename: Comment.docx

pone.0302167.s005.docx (13.9KB, docx)
PLoS One. 2024 May 7;19(5):e0302167. doi: 10.1371/journal.pone.0302167.r002

Author response to Decision Letter 0


13 Feb 2024

I very grateful for reviewers and editors valuable comments.

Attachment

Submitted filename: Authors response to reviewers.docx

pone.0302167.s006.docx (29.8KB, docx)

Decision Letter 1

Mohammed Hasen Badeso

28 Mar 2024

Prevalence of undiagnosed diabetes mellitus and associated factors among adult residents of Mizan Aman town, Southwest Ethiopia: Community-based cross-sectional study

PONE-D-23-12386R1

Dear Author(s),

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice will be generated when your article is formally accepted. Please note, if your institution has a publishing partnership with PLOS and your article meets the relevant criteria, all or part of your publication costs will be covered. Please make sure your user information is up-to-date by logging into Editorial Manager at Editorial Manager® and clicking the ‘Update My Information' link at the top of the page. If you have any questions relating to publication charges, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Mohammed Hasen Badeso, MPH in Field Epidemiology

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Reviewers' comments:

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    S1 Checklist. STROBE statement—Checklist of items that should be included in reports of observational studies.

    (DOCX)

    pone.0302167.s001.docx (44.4KB, docx)
    S1 File

    (DOCX)

    pone.0302167.s002.docx (48.1KB, docx)
    S2 File

    (DOCX)

    pone.0302167.s003.docx (40KB, docx)
    S1 Data

    (SAV)

    pone.0302167.s004.sav (199.7KB, sav)
    Attachment

    Submitted filename: Comment.docx

    pone.0302167.s005.docx (13.9KB, docx)
    Attachment

    Submitted filename: Authors response to reviewers.docx

    pone.0302167.s006.docx (29.8KB, docx)

    Data Availability Statement

    All relevant data are within the paper and its Supporting information files.


    Articles from PLOS ONE are provided here courtesy of PLOS

    RESOURCES